Cyclin A overexpression in carcinoma of the renal pelvis and ureter including dysplasia: Immunohistochemical findings in relation to prognosis

Clinical Cancer Research

Volumn 3, Issue 8, 1997, Pages 1399-1404

  Furihata, Mutsuo ^a   Ohtsuki, Yuji ^a   Sonobe, Hiroshi ^a   Shuin, Taro ^a   Yamamoto, Akihiro ^b   Terao, Naotami ^b   Kuwahara, Morimasa ^c  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b Kochi Takasu Hospital   (Japan)

^c Fujisaki Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A;

ADULT; AGED; ARTICLE; CARCINOGENESIS; DYSPLASIA; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY PELVIS CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; URETER CARCINOMA;

AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CYCLIN A; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; MALE; NEOPLASM INVASIVENESS; NEPHRECTOMY; PROGNOSIS; SURVIVAL ANALYSIS; TIME FACTORS; URETERAL NEOPLASMS;

EID: 0030746261     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. cdc2. Cell, 58: 833-846, 1989.
2. Hunter, T., and Pines, J. Cyclins and cancer. A review. Cell, 66: 1071-1074, 1991.
3. Cordon-Cardo, C. Mutation of cell cycle regulators. Biological and clinical implications for human neoplasia. Am. J. Pathol., 147: 545-560, 1995.
4. Buckley, M. F., Sweeney, K. J., Hamilton, J. A., Sini, R. L., Manning, D. L., Nicholson, R. I., deFazio, A., Watts, C. K., Musgrove. E. A., and Sutherland, R. L. Expression and amplification of cyclin genes in human breast cancer. Oncogene, 8: 2127-2133, 1993.
5. Jiang. W., Zhang, Y. J., Kahn. S. M., Hollstein, M. C.,. Santella. R. M., Lu, S. H., Harris, C. C., Montesano, R., and Weinstein. B. Altered expression of cyclin Dl and retinoblastoma genes in human esophageal cancer. Proc. Natl. Acad. Sci. USA, 90: 9026-9030, 1993.
6. Keyomarsi. K., and Pardee. A. B. Redundant cyclin overexpression and gène amplification in breast cancer cells. Proc. Natl. Acad. Sei. USA. 90: 1112-1116, 1993.
7. Leach, S. F., Elledge, S. J., Sherr, C. J., Wilson, J. K., Markowitz, S., Kinzler, K. W., and Vogelstein, B. Amplification of cyclin genes in colorectal carcinomas. Cancer Res., 53: 1986-1989, 1993.
8. Cong, J., Ardelt, B., Traganos, F., and Darzynkiewicz, Z. Unscheduled expression of cyclin B1 and cyclin E in several leukemic and solid tumor cell lines. Cancer Res., 54: 4285-4288, 1994.
9. Gillett, C., Ranti, V., Smith, R., Fisher, C., Bartek, J., Dickson, C., Barnes, D., and Peters, G. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res., 54: 1812-1817, 1994.
10. Jares, P., Fernandez, P. L., Campo, E., Nadal, A., Bosch, F., Aiza, G., Nayach, I., Traserra, J., and Cardesa, A. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res., 54: 4813-4817, 1994.
11. Keyomarsi, K., O'Leary, N., Molnar, G., Lees, E., Fingert, H. J., and Pardee, A. B. Cyclin E, a potential prognostic marker for breast cancer. Cancer Res., 54: 380-385, 1994.
12. Michalides, R., van Veelen, N., Hart, A., Loftus, B., Wienjens, E., and Balm, A. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res., 55: 975-978, 1995.
13. Betticher, D., Thatcher, N., Altermatt, H. J., Hoban, P., Ryder, W. D. J., and Heighway, J. Alternate splicing produces a novel cyelin D1transcript. Oncogene, 11: 1005-1011, 1995.
14. Keyomarsi, K., Conte, D., Jr., Toyofuku, W., and Fox, M. P. Deregulation of cyclin E in breast cancer. Oncogene, 11: 941-950, 1995.
15. Wang, J., Chenivesse, X., Henglein, B., and Brechot, C. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature (Lond.), 343: 555-557, 1990.
16. Wang, J., Zindy, F., Chenivesse, X., Lamas, E., Henglein, B., and Brechot, C. Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma. Oncogene, 7: 1653-1656, 1992.
17. Giordano, A., McCall, C., Whyte, P., and Franza, B. R. Human cyclin A and the retinoblastoma protein interact with similar but distinguishable sequences in the adenovirus E1A gene product. Oncogene, 6: 481-485, 1991.
18. Faha, B., Ewen, M. E., Tsai, L. H., Livingston, D. M., and Harlow, E. Interaction between human cyclin A and adenovirus E1A-associated p107 protein. Science (Washington DC), 255: 87-90, 1992.
19. Mudryj, M., Devoto, S. H., Hiebert, S. W., Hunter, T., Pines, J., and Nevins, J. R. Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A. Cell, 65: 1243-1253, 1991.
20. Ewen, M. E., Faha, B., Harlow, E., and Livingston, D. M. Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins. Science (Washington DC), 255: 85-87, 1992.
21. Shirodkar, S., Ewan, M., DeCaprio, J. A., Morgan, J., Livingston, D. M., and Chittenden, T. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle regulated manner. Cell, 68: 157-166, 1992.
22. Cao, L., Faha, B., Dembski, M., Tsai, L. H., Harlow, E., and Dyson, N. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature (Lond.), 355: 176-179, 1992.
23. Hofstädter, F., Delgado, R., Jakse, G., and Judmaier, W. Urothelial dysplasia and carcinoma in situ of the bladder. Cancer (Phila.), 57: 356-361, 1986.
24. Lamm, D., Carcinoma in situ. Urol. Clin. North Am., 19: 499-508, 1992.
25. Smith, G., Elton, R. A., Beynon, L. L., Newsam, J. E., Chisholm, G. D., and Hargreare, T. B. Prognostic significance of biopsy results of normal-looking mucosa in cases of superficial bladder cancer. Br. J. Urol., 55: 665-669, 1983.
26. Furihata, M., Yamasaki, L. Ohtsuki, Y., Sonobe, H., Morioka, M., Yamamoto, A., Terao, N., Kuwahara, M., and Fujisaki, N. p53 and human papillomavirus DNA in renal pelvic and ureteral carcinoma including dysplastic lesions. Int. I. Cancer, 64: 298-303, 1995.
27. Furihata, M., Sonobe, H., Ohtsuki, Y., Yamashita, M., Morioka, M., Yamamoto, A., Terao, N., Kuwahara, M., and Fujisaki, N. Detection of p53 and bcl-2 protein in carcinoma of the renal pelvis and ureter including dysplasia. J. Pathol., 178: 133-139, 1996.
28. Arber, N., Hibshoosh, H., Moss, S. F., Sutler, T., Zhang, Y., Begg, M., Wang, S., Weinstein, B., and Holt, P. R. Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterol., 110: 669-674, 1996.
29. Japanese Urological Association and the Society of Pathology, General Rule for Clinical and Pathological Studies on Renal Pelvic and Ureteral Cancer, Ed. 1. Tokyo: Kanehara, 1990.